Company / Interest Expense per Share
Esperion Therapeutics, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.57
FY2023
5-year range
$0.57 / $1.71
FY2019-FY2023
Trend
-33.1%
vs FY2022
Sector context
#10 of 43
Health Care
What the data says
Esperion Therapeutics, Inc.'s interest expense per share of $0.57 is higher than 77% of companies in the Health Care sector (FY2023). Improved from $1.71 to $0.57 over the past 2 years.
Based on SEC 10-K filings.
0.57 in FY2023 with a 5-year CAGR of +252.8%. Top quartile in the Health Care sector.
Improved from $1.71 to $0.57 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -11.5%
- 5-Year CAGR
- +252.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 43This company $0.57 Sector average $18.61
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 33.1% year-over-year.
- Ranks #10 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2021.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.57 | -33.1% |
| FY2022 | $0.86 | -50.0% |
| FY2021 | $1.71 | +107.5% |
| FY2020 | $0.82 | +172.4% |
| FY2019 | $0.30 | +28823.7% |
| FY2018 | $0.00 | -87.3% |
| FY2017 | $0.01 | -50.4% |
| FY2016 | $0.02 | -29.4% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026